Results 181 to 190 of about 2,670,442 (349)

Treatment of stable angina of effort with verapamil: a double-blind, placebo-controlled randomized crossover study. [PDF]

open access: bronze, 1982
Samuel J. Brodsky   +5 more
openalex   +1 more source

Rationale and Design of the PASSIVATE‐CAP Trial: The Preventive Intervention Value of Drug‐Coated Balloons in Vulnerable Coronary Atherosclerotic Plaques

open access: yesClinical Cardiology, Volume 49, Issue 1, January 2026.
PASSIVATE‐CAP Research Overview and Flowchart. ABSTRACT Background Patients with acute coronary syndrome (ACS) face a significantly increased risk of cardiovascular events due to vulnerable plaques. However, no clear evidence supports performing preventive percutaneous coronary intervention (PCI) for non‐flow‐limiting vulnerable plaques.
Zhongxiu Chen   +11 more
wiley   +1 more source

COMPARISON OF EFFECTIVENESS OF PERCUTANEOUS CORONARY INTERVENTION AND MEDICATION IN PATIENTS WITH STABLE ANGINA

open access: yesGomal Journal of Medical Sciences, 2015
Stable angina is one of the main manifestations of coronary artery disease. The presence of angina symptoms, a positive exercise test for myocardial ischaemia and confirmation of coronary artery atherosclerosis by coro¬nary angiography are the bases of ...
Afzal Qasim   +2 more
doaj  

The Effect of Age on Improvement in Health‐Related Quality of Life After Percutaneous Coronary Intervention

open access: yesClinical Cardiology, Volume 49, Issue 1, January 2026.
The effect of age on improvement in health‐related quality of life (HRQoL) after percutaneous coronary intervention (PCI)—Do older adults benefit from PCI equally to their younger peers in respect of HRQoL and symptom relief? ABSTRACT Introduction Percutaneous coronary intervention (PCI) is the first‐line therapy in patients scheduled for coronary ...
Laura Lappalainen   +6 more
wiley   +1 more source

Assessment of effectiveness and acceptability of combination of L-carnitine and arginine hydrochloride in patients with stable effort angina

open access: diamond, 2019
И. М. Фуштей   +3 more
openalex   +2 more sources

Impact of Antihypertensive Treatment on Outcomes of Adjuvant Bevacizumab for Ovarian Cancer (IATRO), Results from a Nationwide Emulated Clinical Trial

open access: yesClinical Pharmacology &Therapeutics, Volume 119, Issue 1, Page 198-207, January 2026.
Antiangiogenic therapy with bevacizumab improves outcomes in ovarian cancer but induces hypertension, leading to major adverse cardiovascular events (MACE). While calcium channel blockers (CCBs) and angiotensin‐converting enzyme inhibitors (ACEi) are recommended for managing bevacizumab‐associated hypertension, their impacts on cancer progression and ...
Floriane Jochum   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy